ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
3,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,Y
4,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4,2,Calcinosis,Trophic disorders,Tissue disorders NEC,Genrl,N
5,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
5,3,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
6,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
7,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
9,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
9,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
